Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 19, Pp 2320-2331 (2018)
Background: XB130 is a recently discovered adaptor protein that is highly expressed in many malignant tumors, but few studies have investigated its role in hepatocellular carcinoma (HCC). Therefore, this study explored the relationship between this p
Externí odkaz:
https://doaj.org/article/f670b31898024e93a5daf51e1dde9e59
Autor:
Xing-Wang Xie, Xue-Yan Wang, Wei-Jia Liao, Ran Fei, Xu Cong, Qian Chen, Lai Wei, Hong-Song Chen, Yu Wang
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 23, Pp 2827-2835 (2018)
Background: DNA replication and sister chromatid cohesion 1 (DSCC1) (also called DCC1) is a component of an alternative replication factor C complex that loads proliferating cell nuclear antigen onto DNA during S phase of the cell cycle. It is locate
Externí odkaz:
https://doaj.org/article/7a0aa9fa0596482a98e1af0b9f3a4961
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 20, Pp 2410-2416 (2018)
Background: The diagnosis and treatment of small hepatocellular carcinoma (HCC) play a vital role in the prognosis of patients with HCC. The purpose of our study was to evaluate angio-computed tomography (angio-CT)-guided immediate lipiodol CT (a CT
Externí odkaz:
https://doaj.org/article/87e91b5d928e44efae4c07df722032f4
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 14, Pp 1670-1676 (2017)
Background: Orthotopic liver transplantation (OLT) improves the prognosis of patients with hepatocellular carcinoma (HCC). Moreover, the complement system is a powerful immune effector that can affect liver function and process of liver cirrhosis. Ho
Externí odkaz:
https://doaj.org/article/125c8bab060c4bafb54f62a838803337
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 4, Pp 470-476 (2017)
Background: Human U three protein 14a (hUTP14a) promotes p53 degradation. Moreover, hUTP14a expression is upregulated in several types of tumors. However, the expression pattern of hUTP14a in hepatocellular carcinoma (HCC) remains unknown. The aim of
Externí odkaz:
https://doaj.org/article/cc649c8c84024d1fa7bb2ab01425d40d
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 22, Pp 2686-2690 (2017)
Background: Overexpression and constitutive activation of signal transducer and activator of transcription (STAT) 3 have been suggested in the tumorigenesis of many human cancers, including multiple carcinomas, melanoma, and lymphoma. The diagnosis o
Externí odkaz:
https://doaj.org/article/965ed81ed5444dfc863e10d67551263c
Autor:
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, Wei Li, Jian Yu, Xiao-Dong Zhu, Yong Xia, Ti Zhang, Yang Xu, Bo Hu, Li-Ping Du, Ling-Yao Zeng, Jian Ouyang, Wei Zhang, Tian-Qiang Song, Qiang Li, Ying-Hong Shi, Jian Zhou, Shuang-Jian Qiu, Qian Liu, Yi-Xue Li, Zhao-You Tang, Yu Shyr, Feng Shen, Jia Fan
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 22, Pp 2650-2660 (2017)
Background: For Chinese patients with hepatocellular carcinoma (HCC), surgical resection is the most important treatment to achieve long-term survival for patients with an early-stage tumor, and yet the prognosis after surgery is diverse. We aimed to
Externí odkaz:
https://doaj.org/article/ee49e02b78cb40b3853111cc0ae34bd9
Publikováno v:
Chinese Medical Journal, Vol 129, Iss 21, Pp 2623-2629 (2016)
Background: Decoy receptor 3 (DcR3) binds to Fas ligand (FasL) and inhibits FasL-induced apoptosis. The receptor is overexpressed in hepatocellular carcinoma (HCC), and it is associated with the growth and metastatic spread of tumors. DcR3 holds prom
Externí odkaz:
https://doaj.org/article/b44eb4945cb4472fa40985b4e3d8d7d9
Publikováno v:
Chinese Medical Journal, Vol 129, Iss 5, Pp 536-541 (2016)
Background: The absolute lymphocyte counts (ALCs) have been reported as one of worse prognostic factors for hepatocellular carcinoma (HCC) patient after liver transplantation. The aim of this study was to assess the influence of ALCs on the outcomes
Externí odkaz:
https://doaj.org/article/dec8b7f3f66740148d5713d814f129fc
Publikováno v:
Chinese Medical Journal, Vol 128, Iss 10, Pp 1384-1390 (2015)
Background: Human sulfatase-1 (Hsulf-1) is an endosulfatase that selectively removes sulfate groups from heparan sulfate proteoglycans (HSPGs), altering the binding of several growth factors and cytokines to HSPG to regulate cell proliferation, cell
Externí odkaz:
https://doaj.org/article/485b1e0f0c7b40ffb180c8ac24fe7e02